|
WO1995031183A1
(en)
|
1994-05-16 |
1995-11-23 |
Washington University |
Cell membrane fusion composition and method
|
|
GB9710809D0
(en)
|
1997-05-23 |
1997-07-23 |
Medical Res Council |
Nucleic acid binding proteins
|
|
WO1999013905A1
(en)
|
1997-09-18 |
1999-03-25 |
The Trustees Of The University Of Pennsylvania |
Receptor-binding pocket mutants of influenza a virus hemagglutinin for use in targeted gene delivery
|
|
AU746454B2
(en)
|
1998-03-02 |
2002-05-02 |
Massachusetts Institute Of Technology |
Poly zinc finger proteins with improved linkers
|
|
US6534261B1
(en)
|
1999-01-12 |
2003-03-18 |
Sangamo Biosciences, Inc. |
Regulation of endogenous gene expression in cells using zinc finger proteins
|
|
US7013219B2
(en)
|
1999-01-12 |
2006-03-14 |
Sangamo Biosciences, Inc. |
Regulation of endogenous gene expression in cells using zinc finger proteins
|
|
US6794136B1
(en)
|
2000-11-20 |
2004-09-21 |
Sangamo Biosciences, Inc. |
Iterative optimization in the design of binding proteins
|
|
US7030215B2
(en)
|
1999-03-24 |
2006-04-18 |
Sangamo Biosciences, Inc. |
Position dependent recognition of GNN nucleotide triplets by zinc fingers
|
|
US20030104526A1
(en)
|
1999-03-24 |
2003-06-05 |
Qiang Liu |
Position dependent recognition of GNN nucleotide triplets by zinc fingers
|
|
CA2392490A1
(en)
|
1999-11-24 |
2001-05-31 |
Mcs Micro Carrier Systems Gmbh |
Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells
|
|
US20040028687A1
(en)
|
2002-01-15 |
2004-02-12 |
Waelti Ernst Rudolf |
Methods and compositions for the targeted delivery of therapeutic substances to specific cells and tissues
|
|
US20030232410A1
(en)
|
2002-03-21 |
2003-12-18 |
Monika Liljedahl |
Methods and compositions for using zinc finger endonucleases to enhance homologous recombination
|
|
JP2005521398A
(ja)
|
2002-03-27 |
2005-07-21 |
ベイラー カレッジ オブ メディスン |
癌治療用の強力な腫瘍溶解性単純ヘルペスウイルス
|
|
PL377161A1
(pl)
|
2002-11-21 |
2006-01-23 |
Pevion Biotech Ltd. |
Wysoce efektywne pęcherzyki fuzogenne, sposób ich wytwarzania oraz kompozycje farmaceutyczne zawierające te pęcherzyki
|
|
AU2004208031B2
(en)
|
2003-01-28 |
2009-10-08 |
Cellectis |
Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof.
|
|
US7842673B2
(en)
|
2003-12-17 |
2010-11-30 |
The Trustees Of Columbia University In The City Of New York |
Delivery of DNA or RNA via gap junctions from host cells to target cells and a cell-based delivery system for antisense or siRNA
|
|
WO2006027202A1
(en)
|
2004-09-06 |
2006-03-16 |
Unite De Recherche En Biotherapie Et Oncologie (Rubio) |
Generation of multiparent cell hybrids
|
|
AU2006224248B2
(en)
|
2005-03-15 |
2011-01-06 |
Cellectis |
I-Crei meganuclease variants with modified specificity, method of preparation and uses thereof
|
|
EP2650366B1
(en)
|
2005-10-18 |
2017-03-22 |
Precision Biosciences |
Rationally designed meganucleases with altered sequence specificity and DNA-binding affinity
|
|
WO2007099387A1
(en)
|
2006-03-03 |
2007-09-07 |
Mymetics Corporation |
Virosome-like vesicles comprising gp41-derived antigens
|
|
JP2009533065A
(ja)
|
2006-04-20 |
2009-09-17 |
ジボダン エス エー |
味覚物質同定のための機能的方法
|
|
US9085778B2
(en)
|
2006-05-03 |
2015-07-21 |
VL27, Inc. |
Exosome transfer of nucleic acids to cells
|
|
US20090203140A1
(en)
|
2007-09-27 |
2009-08-13 |
Sangamo Biosciences, Inc. |
Genomic editing in zebrafish using zinc finger nucleases
|
|
EP2419144B1
(en)
|
2009-04-17 |
2019-08-07 |
Oxford University Innovation Limited |
Composition for delivery of genetic material
|
|
JP5878126B2
(ja)
|
2009-11-13 |
2016-03-08 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
工学操作された微小胞を用いての直接的なタンパク質の送達
|
|
NO2510096T3
(enExample)
|
2009-12-10 |
2015-03-21 |
|
|
|
EP3608308B1
(en)
|
2013-03-08 |
2021-07-21 |
Novartis AG |
Lipids and lipid compositions for the delivery of active agents
|
|
SG11201508433TA
(en)
|
2013-04-12 |
2015-11-27 |
Andaloussi Samir El |
Therapeutic delivery vesicles
|
|
PT3083556T
(pt)
|
2013-12-19 |
2020-03-05 |
Novartis Ag |
Lípidos e composições lipídicas para a entrega de agentes ativos
|
|
US20170173113A1
(en)
|
2014-03-13 |
2017-06-22 |
Research Institute At Nationwide Children's Hospital |
Methods of delivering heparin binding epidermal growth factor using stem cell generated exosomes
|
|
IL256175B2
(en)
|
2015-06-10 |
2024-10-01 |
Univ Texas |
Using exosomes to treat the disease
|
|
WO2017068077A1
(en)
*
|
2015-10-20 |
2017-04-27 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Methods and products for genetic engineering
|
|
US20170112773A1
(en)
|
2015-10-23 |
2017-04-27 |
Board Of Regents, The University Of Texas System |
Plasma membrane vesicles comprising functional transmembrane proteins
|
|
SG10202104041PA
(en)
|
2015-10-23 |
2021-06-29 |
Harvard College |
Nucleobase editors and uses thereof
|
|
SI3436077T1
(sl)
|
2016-03-30 |
2025-07-31 |
Intellia Therapeutics, Inc. |
Formulacije lipidnih nanodelcev za komponente crispr/cas
|
|
GB201609216D0
(en)
|
2016-05-25 |
2016-07-06 |
Evox Therapeutics And Isis Innovation Ltd |
Exosomes comprising therapeutic polypeptides
|
|
GB2552301A
(en)
|
2016-07-11 |
2018-01-24 |
Evox Therapeutics Ltd |
Metabolic drug loading of EVs
|
|
GB2552460A
(en)
|
2016-07-11 |
2018-01-31 |
Evox Therapeutics Ltd |
CPP-Mediated EV Loading
|
|
KR20250103795A
(ko)
|
2016-08-03 |
2025-07-07 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
아데노신 핵염기 편집제 및 그의 용도
|
|
CN110072994A
(zh)
|
2016-12-23 |
2019-07-30 |
埃克波菲尔有限公司 |
用于纯化或分离微泡和外泌体的方法与组合物
|
|
GB201702863D0
(en)
|
2017-02-22 |
2017-04-05 |
Evox Therapeutics Ltd |
Improved loading of EVs with therapeutic proteins
|
|
WO2018165629A1
(en)
|
2017-03-10 |
2018-09-13 |
President And Fellows Of Harvard College |
Cytosine to guanine base editor
|
|
WO2018176009A1
(en)
|
2017-03-23 |
2018-09-27 |
President And Fellows Of Harvard College |
Nucleobase editors comprising nucleic acid programmable dna binding proteins
|
|
AU2018316803B2
(en)
|
2017-08-17 |
2021-07-15 |
Ilias Biologics Inc. |
Exosomes for target specific delivery and methods for preparing and delivering the same
|
|
FI3688162T3
(fi)
|
2017-09-29 |
2024-05-15 |
Intellia Therapeutics Inc |
Formulaatioita
|
|
US11795443B2
(en)
|
2017-10-16 |
2023-10-24 |
The Broad Institute, Inc. |
Uses of adenosine base editors
|
|
GB201717446D0
(en)
|
2017-10-24 |
2017-12-06 |
Evox Therapeutics Ltd |
Affinity purification of engineering extracellular vesicles
|
|
AU2018358051B2
(en)
|
2017-11-01 |
2025-01-09 |
The Regents Of The University Of California |
CasZ compositions and methods of use
|
|
US11970719B2
(en)
|
2017-11-01 |
2024-04-30 |
The Regents Of The University Of California |
Class 2 CRISPR/Cas compositions and methods of use
|
|
GB201802163D0
(en)
|
2018-02-09 |
2018-03-28 |
Evox Therapeutics Ltd |
Compositions for EV storage and formulation
|
|
GB201804291D0
(en)
|
2018-03-16 |
2018-05-02 |
Evox Therapeutics Ltd |
Cell-mediated exosome delivery
|
|
KR20250133482A
(ko)
|
2018-05-11 |
2025-09-05 |
빔 테라퓨틱스, 인크. |
프로그래밍가능한 염기 편집기 시스템을 이용하여 단일 뉴클레오티드 다형성을 편집하는 방법
|
|
EP3790964A4
(en)
|
2018-05-11 |
2022-06-08 |
Beam Therapeutics, Inc. |
METHODS FOR REMOVAL OF PATHOGENIC MUTATIONS USING PROGRAMMABLE BASE EDITOR SYSTEMS
|
|
US12157760B2
(en)
|
2018-05-23 |
2024-12-03 |
The Broad Institute, Inc. |
Base editors and uses thereof
|
|
CN112805379B
(zh)
|
2018-08-03 |
2024-08-20 |
比姆医疗股份有限公司 |
多效应核碱基编辑器和使用其修饰核酸靶序列的方法
|
|
EP3850088A4
(en)
|
2018-09-07 |
2023-07-19 |
Beam Therapeutics, Inc. |
Compositions and methods for improving base editing
|
|
AU2019336245B2
(en)
|
2018-09-07 |
2026-02-26 |
Beam Therapeutics Inc. |
Compositions and methods for delivering a nucleobase editing system
|
|
US20220380740A1
(en)
|
2018-10-24 |
2022-12-01 |
The Broad Institute, Inc. |
Constructs for improved hdr-dependent genomic editing
|
|
EP3880717A4
(en)
*
|
2018-11-16 |
2022-11-23 |
The Regents of The University of California |
Compositions and methods for delivering crispr/cas effector polypeptides
|
|
WO2020160481A1
(en)
|
2019-02-01 |
2020-08-06 |
The General Hospital Corporation |
Targetable 3'-overhang nuclease fusion proteins
|
|
EP3942043A2
(en)
|
2019-03-19 |
2022-01-26 |
The Broad Institute, Inc. |
Methods and compositions for editing nucleotide sequences
|
|
CN114258398A
(zh)
|
2019-06-13 |
2022-03-29 |
总医院公司 |
工程化的人内源性病毒样颗粒及使用其递送至细胞的方法
|
|
CN119913134A
(zh)
|
2019-08-29 |
2025-05-02 |
比姆医疗股份有限公司 |
用于编辑突变以允许转录或表达的组合物和方法
|
|
AU2020345830A1
(en)
|
2019-09-09 |
2022-03-24 |
Beam Therapeutics Inc. |
Novel CRISPR enzymes, methods, systems and uses thereof
|
|
US12435330B2
(en)
|
2019-10-10 |
2025-10-07 |
The Broad Institute, Inc. |
Methods and compositions for prime editing RNA
|
|
CN121759549A
(zh)
|
2019-12-03 |
2026-03-31 |
比姆医疗股份有限公司 |
合成向导rna、其组合物、方法和用途
|
|
BR112022022603A2
(pt)
|
2020-05-08 |
2023-01-17 |
Broad Inst Inc |
Métodos e composições para edição simultânea de ambas as fitas de sequência alvo de nucleotídeos de fita dupla
|
|
US12565647B2
(en)
*
|
2021-05-28 |
2026-03-03 |
The Regents Of The University Of California |
Compositions and methods for targeted delivery of CRISPR-Cas effector polypeptides and transgenes
|
|
EP4351660A2
(en)
*
|
2021-06-09 |
2024-04-17 |
Scribe Therapeutics Inc. |
Particle delivery systems
|